David J Salant Selected Research

Membranous Glomerulonephritis (Membranous Nephropathy)

1/2021	Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
8/2019	Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy?
1/2019	Unmet challenges in membranous nephropathy.
11/2018	Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele.
1/2017	An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
5/2016	Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report.
12/2014	Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
7/2014	Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study.
12/2013	Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy.
4/2012	Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Salant Research Topics

Disease

23	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2021 - 04/2002
14	Proteinuria 01/2019 - 04/2002
7	Kidney Diseases (Kidney Disease) 01/2021 - 04/2002
7	Glomerulonephritis 01/2018 - 07/2010
6	Nephritis 12/2017 - 04/2002
4	Renal Insufficiency (Renal Failure) 01/2018 - 05/2005
4	Inflammation (Inflammations) 12/2017 - 04/2002
4	Autoimmune Diseases (Autoimmune Disease) 06/2014 - 04/2002
3	Fibrosis (Cirrhosis) 06/2021 - 07/2005
3	Albuminuria 09/2004 - 05/2002
2	Chronic Renal Insufficiency 06/2021 - 03/2018
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 06/2021 - 02/2012
2	Edema (Dropsy) 05/2016 - 04/2012
1	Infections 06/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 12/2017
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 12/2016
1	Mowat-Wilson syndrome 12/2016
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2016
1	Hypercholesterolemia 07/2016
1	Hypoalbuminemia 05/2016
1	Neoplasms (Cancer) 12/2013
1	Hypertension (High Blood Pressure) 04/2012
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 02/2012
1	Immunoglobulin G4-Related Disease 01/2012
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2012
1	Atypical Hemolytic Uremic Syndrome 01/2011
1	Ureteral Obstruction 01/2011
1	Hydronephrosis 01/2011
1	Purpura 07/2010
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 07/2010
1	IGA Glomerulonephritis (IGA Nephropathy) 07/2009
1	Vasculitis (Vasculitides) 01/2008
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 09/2007
1	Rare Diseases (Rare Disease) 09/2007
1	Hypertrophy 07/2005

Drug/Important Bio-Agent (IBA)

15	AutoantibodiesIBA 01/2021 - 02/2004
10	AntibodiesIBA 01/2018 - 09/2004
8	Phospholipase A2 ReceptorsIBA 01/2021 - 07/2009
8	AntigensIBA 01/2019 - 01/2009
7	Immunoglobulin G (IgG)IBA 01/2021 - 05/2002
6	Proteins (Proteins, Gene)FDA Link 06/2021 - 04/2002
4	CreatinineIBA 06/2021 - 05/2002
4	Complement System Proteins (Complement)IBA 01/2019 - 05/2002
4	Phospholipases (Phospholipase)IBA 05/2016 - 06/2011
3	Rituximab (Mabthera)FDA Link 08/2019 - 09/2007
3	EpitopesIBA 08/2019 - 07/2009
3	ThrombospondinsIBA 01/2019 - 12/2014
3	AutoantigensIBA 01/2019 - 06/2011
3	nephrinIBA 06/2005 - 04/2002
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 12/2016
2	Methylprednisolone FDA LinkGeneric 04/2012 - 01/2008
2	CD55 Antigens (Decay Accelerating Factor)IBA 02/2004 - 05/2002
1	PF-06730512IBA 06/2021
1	LectinsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2019
1	HLA-DRB1 Chains (HLA DRB1)IBA 11/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2017
1	UbiquitinIBA 12/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2017
1	Proprotein Convertase 9IBA 07/2016
1	LipidsIBA 07/2016
1	PCSK9 InhibitorsIBA 07/2016
1	CholesterolIBA 07/2016
1	A 7 (A-7)IBA 07/2016
1	Caspase 8 (Caspase-8)IBA 07/2016
1	AlbuminsIBA 05/2016
1	Abatacept (Orencia)FDA Link 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2014
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2012
1	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2012
1	ErbB Receptors (EGF Receptor)IBA 09/2011
1	superoxide dismutase 2IBA 08/2011
1	Complement C5 (Complement 5)IBA 01/2011
1	Contrast MediaIBA 01/2011
1	KininsIBA 07/2010
1	MethyltransferasesIBA 05/2010
1	Glycoproteins (Glycoprotein)IBA 07/2009
1	Immunoglobulins (Immunoglobulin)IBA 07/2009
1	Dichlorodiphenyldichloroethane (DDD)IBA 09/2007
1	eculizumab FDA Link 09/2007
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 09/2007
1	CollagenIBA 06/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2007
1	Dexfenfluramine (Redux)IBA 10/2005
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 10/2005
1	Therapeutic UsesIBA 07/2005

Therapy/Procedure

3	Therapeutics 01/2019 - 05/2005
1	Organ Transplantation 06/2021
1	Traction 01/2021
1	Transplantation 12/2017
1	Plasmapheresis 04/2012
1	Microbubbles 01/2011
1	Plasma Exchange 01/2008